← Evidence map

TrialVaccine2009

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.

Lindvi Gudmundsdotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

41 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19450644